• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 10220
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Hemolysis (1886)
Event Date 06/09/2023
Event Type  malfunction  
Event Description
The customer called and reported that the interface was not properly establishing during a therapeutic plasma exchange (tpe) on a lung transplant patient.The customer reported that the lab had problems with the labs and that the plasma was red tinged in the centrifuge.They said that they would need to call the physician at the site to determine if they could continue the run.They checked the fluids and the correct fluids were attached on each spike.They paused the procedure with a kvo and asked how long they could keep the machine running with the patient on it while they contacted the physician.Patient information and outcome are unknown at this time.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Lot number and expiry information are not available at this time.Investigation is in process, a follow-up report will be provided.
 
Manufacturer Narrative
Investigation: the customer did not respond to multiple attempts to obtain information for the investigation such as patient (recipient) information, recipient outcome, procedural details and lot information.The lot number was not provided, therefore, a dhr search could not be conducted for this specific incident.All lots must meet acceptance criteria for release.Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer called and reported that the interface was not properly establishing during a therapeutic plasma exchange (tpe) on a lung transplant patient.The customer reported that the lab had problems with the labs and that the plasma was red tinged in the centrifuge.They said that they would need to call the physician at the site to determine if they could continue the run.They checked the fluids and the correct fluids were attached on each spike.They paused the procedure with a kvo and asked how long they could keep the machine running with the patient on it while they contacted the physician.Patient information and outcome are unknown at this time.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigation: the customer did not respond to multiple attempts to obtain information for the investigation such as patient (recipient) information, recipient outcome, procedural details and lot information.The lot number was not provided, therefore, a dhr search could not be conducted for this specific incident.All lots must meet acceptance criteria for release.Root cause: a root cause assessment was performed for this complaint.Based on the available information a definitive root cause for hemolysis could not be determined but it is likely due to one or a combination of the possible causes listed below: hemolysis due to inlet needle replaced with smaller diameter or incompletely broken septum resulting in rbcs exposed to pressure drop in the inlet line.Hemolysis due to pinched inlet line resulting in rbcs exposed to pressure drop in inlet line.The residual total risk is determined to be low.Hemolysis due to an occlusion in the tubing resulting in rbcs exposed to a pressure drop.
 
Event Description
The customer called and reported that the interface was not properly establishing during a therapeutic plasma exchange (tpe) on a lung transplant patient.The customer reported that the lab had problems with the labs and that the plasma was red tinged in the centrifuge.They said that they would need to call the physician at the site to determine if they could continue the run.They checked the fluids and the correct fluids were attached on each spike.They paused the procedure with a kvo and asked how long they could keep the machine running with the patient on it while they contacted the physician.Patient information and outcome are unknown at this time.The collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key17229480
MDR Text Key318132649
Report Number1722028-2023-00224
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/29/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number10220
Device Catalogue Number10220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/20/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-